Marketing of Clozaril [microform] : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.
United States.Congress.Senate.Committee on the Judiciary.Subcommittee on Antitrust, Monopolies, and Business Rights.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1991.
"Serial no. J-102-6."
Includes bibliographical references.
Microfiche.
Sandoz Pharmaceuticals Corporation.
Clozapine
Drugs
Medical care